Fundz

Renasant Bio reported raising $25.5 Million in an initial SEC Form D filing, from an offering of $25.5 Million

PRIVATEJul 14, 2025Late filing, first sale Jul 15, 2024

Amount Raised

$25.5 Million

$25.5 Million sold, per SEC Form D (first sale Jul 15, 2024)

Round Type

Venture

BerkeleyBiotechnologyHealth CareTherapeutics

Quick answer

Renasant Bio raised $25.5 Million in a funding round, dated July 15, 2024. Renasant Bio is based in Berkeley, California, United States.

How much did Renasant Bio raise?
Renasant Bio raised $25.5 Million in a funding round on July 15, 2024.
What does Renasant Bio do?
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments for autosomal dominant polycystic kidney disease (ADPKD), the leading genetic cause of end-stage renal failure.
Where is Renasant Bio based and how big is it?
Renasant Bio is based in Berkeley, California, United States. Fundz records about 15 employees.
Who are the decision-makers at Renasant Bio?
Fundz holds 1 contact at Renasant Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Renasant Bio that raised within 45 days of this round, from Fundz verified event records.

  • Navigator Medicines raised $100M (Series A) on August 27, 2024.
  • Radiant raised $34M on August 27, 2024.
  • Diakonos Oncology raised $11M (Seed) on August 26, 2024.
  • Navigator Medicines raised $50M on August 23, 2024.
  • Borealis Biosciences raised $150M (Series A) on August 22, 2024.
  • Retension Pharmaceuticals raised $10M (Series A) on August 21, 2024.

Who to call at Renasant Bio, and when

A new round usually means Renasant Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Renasant Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Renasant Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Renasant Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Renasant Bio

Location

Berkeley, California, United States

About

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments for autosomal dominant polycystic kidney disease (ADPKD), the leading genetic cause of end-stage renal failure. Renasant is advancing a pipeline of oral small molecule corrector and potentiator programs that target the underlying biology of ADPKD to restore the function of key proteins to halt disease progression.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Renasant Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Renasant Bio's next move

See what Strategic adds

Renasant Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.